+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease



Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease



Clinical Gastroenterology and Hepatology 7(4): 481-486



Liver biopsy is required to diagnose nonalcoholic steatohepatitis (NASH) in patients with suspected non-alcoholic fatty liver disease (NAFLD); recent studies suggested significant sampling variability. Using percutaneous liver biopsy samples from patients with suspected NAFLD, we examined the relationship between histological yield and length of biopsies, number of cores and number of independent readings. Three cores of liver tissue were collected, by percutaneous liver biopsy, from each of 50 patients suspected to have NAFLD. The diagnostic yield (percent with definite NASH) and other histological findings from 2 independent, blinded examinations of 2 cores and from all 3 cores combined were assessed. Steatosis, lobular inflammation and fibrosis scores were significantly higher when 3 samples were analyzed, compared with 2. However, between groups, there were no significant differences in hepatocyte ballooning, proportion with an NAFLD activity score > or =4 or proportion with definite NASH (57% vs 61%, P = .3). The length of the biopsy sample correlated with percentage of patients found to have definite NASH (29%, 46%, 56%, and 65% in biopsies measuring <10 mm, 10-14 mm, 15-24 mm, and > or =25 mm, respectively; P < .0001). When biopsy specimens were read twice by the same pathologist, the composite of the 2 independent readings yielded a significantly higher yield for several histological features, compared with the first reading. There is a significant relationship between histological yield and sample length and number of independent readings of liver biopsy samples. More studies are needed to optimize the strategy for liver biopsy, to more effectively assess histology in patients with suspected NAFLD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052873966

Download citation: RISBibTeXText

PMID: 19162235

DOI: 10.1016/j.cgh.2008.12.015


Related references

Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7): 1898-1906, 2005

Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?. JAMA 308(6): 608-616, 2012

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology 20(2): 475-485, 2014

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 24(4): 564-568, 2009

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clinic Proceedings 90(9): 1233-1246, 2015

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140(1): 124-131, 2011

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63(6): 1817-1827, 2017

Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Liver Transplantation 20(9): 1064-1071, 2015

Acoustic Radiation Force Impulse Is Equivalent to Liver Biopsy to Evaluate Liver Fibrosis in Patients with Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease. Arquivos de Gastroenterologia 52(3): 234-238, 2016

Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation. Hepatology Communications 1(5): 370-378, 2018

Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?. Cleveland Clinic Journal of Medicine 84(4): 273-275, 2018

Nonalcoholic fatty liver disease in a severely obese adolescent. An arguable liver biopsy. Archives de Pediatrie 18(1): 62-65, 2011

The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease. Journal of Medicine and Life 11(3): 243-246, 2018

Weight loss outcomes after liver biopsy in patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 46(12): 1136-1137, 2015

Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?. Journal of Gastrointestinal Surgery 12(12): 2097-102; Discussion 2102, 2008